Trade

with

Prana Biotechnology Ltd
(NASDAQ: PRAN)
AdChoices
=
1.97
0.00
0.00%
After Hours :
1.97
0.00
0.00%

Open

1.98

Previous Close

1.97

Volume (Avg)

148.72k (842.44k)

Day's Range

1.93-1.99

52Wk Range

1.47-13.29

Market Cap.

82.05M

Dividend Rate ( Yield )

-

Beta

0.63

Shares Outstanding

41.65M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 4.07M

    • Net Income

    • -6.84M

    • Market Cap.

    • 82.05M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -285.73

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.63

    • Forward P/E

    • -

    • Price/Sales

    • 21.46

    • Price/Book Value

    • 4.73

    • Price/Cash flow

    • -7.91

      • EBITDA

      • -6.80M

      • Return on Capital %

      • -60.98

      • Return on Equity %

      • -77.82

      • Return on Assets %

      • -60.98

      • Book Value/Share

      • 0.37

      • Shares Outstanding

      • 41.65M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 4.67

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -0.04

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -12.30

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 56.64

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -285.73

            • 39.38

            • Net Profit Margin

            • -285.73

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 100.00

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -1,706.60

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -1,706.60

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 5.16

              • 2.92

              • Quick Ratio

              • 5.13

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.24

              • 2.21

              • Book Value/Share

              • 0.42

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -7.52

                • 196.08

                • P/E Ratio 5-Year High

                • -50.76

                • 634.30

                • P/E Ratio 5-Year Low

                • -3.90

                • 124.82

                • Price/Sales Ratio

                • 21.51

                • 9.12

                • Price/Book Value

                • 4.73

                • 8.26

                • Price/Cash Flow Ratio

                • -7.91

                • 47.39

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -77.82

                    (-97.70)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -60.98

                    (-77.50)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -77.82

                    (-96.00)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • 0.21

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -6.85M
                  Operating Margin
                  -168.17
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -7.91
                  Ownership

                  Institutional Ownership

                  2.36%

                  Top 10 Institutions

                  2.03%

                  Mutual Fund Ownership

                  0.01%

                  Float

                  -

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® NASDAQ Composite Index® Fund

                  •  

                    3,293

                  • 0.00

                  • 0.01

                  • Fidelity® Nasdaq Composite Tr Stk Fund

                  •  

                    1,335

                  • 9.52

                  • 0.00

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Susquehanna Financial Group, LLLP

                  •  

                    241,750

                  • +10.98%

                  • 0.58

                  • Garrison Bradford & Associates Inc

                  •  

                    129,342

                  • -4.08%

                  • 0.31

                  • JANE STREET GROUP, LLC

                  •  

                    128,660

                  • +102.13%

                  • 0.31

                  • Columbia Asset Management, L.L.C.

                  •  

                    64,150

                  • +5.34%

                  • 0.15

                  • Morgan Stanley & Co Inc

                  •  

                    63,855

                  • +38.36%

                  • 0.15

                  • Group One Trading, LP

                  •  

                    58,238

                  • -21.19%

                  • 0.14

                  • Columbia Management Company

                  •  

                    39,000

                  • -18.75%

                  • 0.09

                  • Goldman, Sachs & Co.

                  •  

                    36,096

                  • -20.27%

                  • 0.09

                  • Citadel Advisors Llc

                  •  

                    31,687

                  • -73.49%

                  • 0.08

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  Prana Biotechnology Ltd was incorporated on November 11, 1997. The Company is a development stage company at an early stage in the development of its pharmaceutical products. The Company’s activities include research into Alzheimer ’s disease and other major age-related degenerative disorders.

                  Key People

                  Geoffrey P. Kempler

                  CEO/Chairman of the Board/Director

                  Richard Revelins

                  CFO/Secretary

                  Brian D. Meltzer

                  Director

                  George W. Mihaly

                  Director

                  Peter Marks

                  Director

                  • Prana Biotechnology Ltd

                  • 369 Royal Parade

                  • Parkville, VIC 3052

                  • AUS.Map

                  • Phone: +61 393494906

                  • Fax: +61 393480377

                  • pranabio.com

                  Incorporated

                  1997

                  Employees

                  9

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: